Melanotan II inhibits presynaptic N-type calcium channels by activating melanocortin 4 receptors in amygdala neurons.
Background
The melanocortin 4 receptor (MC4R) is a G protein-coupled receptor crucial for regulating food intake and energy balance. Activation of MC4R is known to modify neuronal activity, but the specific molecular mechanisms underlying this regulation are not fully understood. It is hypothesized that MC4R exerts its effects by modulating voltage-gated calcium channels, which in turn would regulate synaptic activity. This study focuses on the amygdala, a brain region recognized for mediating the appetite-suppressing (anorexigenic) actions of MC4R signaling. Clarifying this pathway could provide a deeper understanding of how melanocortins control appetite.
Study Design
Researchers used the patch-clamp technique to measure calcium currents. First, they studied HEK293 cells transiently transfected with MC4R and N-type calcium channels, applying the agonist melanotan II in a concentration-dependent manner. They also tested the Gαs pathway inhibitor cholera toxin. Next, they performed similar experiments on cultured amygdala neurons from mice. In vivo, mice were administered the MC4R agonist RO27-3225 or the N-type channel blocker ω conotoxin GVIA to observe changes in the cellular activity marker c-Fos within the amygdala.
Results
Activation of MC4R with melanotan II specifically inhibited N-type calcium currents. In transfected HEK293 cells, this inhibition was concentration-dependent and voltage-independent, reaching 34.5 ± 1.5%. This effect was occluded by the Gαs pathway inhibitor cholera toxin, confirming the mechanism. In native mouse amygdala neurons, melanotan II inhibited N-type calcium currents by 25.9 ± 2.0%. Furthermore, it reduced evoked inhibitory postsynaptic currents by 55.4 ± 14.4% in these neurons.
In vivo, the
MC4Ragonist RO27-3225 increasedc-Fosexpression in several parts of the amygdala, while the N-type channel blocker ω conotoxin GVIA only increased it in the central subdivision. This suggests the inhibition of presynaptic N-type channels is a key mechanism for melanocortin action specifically within the central amygdala.
Key Findings
- Melanotan II inhibited N-type calcium currents by 34.5 ± 1.5% in transfected HEK293 cells.
- In cultured mouse amygdala neurons, Melanotan II inhibited native N-type calcium currents by 25.9 ± 2.0%.
- Melanotan II reduced evoked inhibitory postsynaptic currents by 55.4 ± 14.4% in amygdala neurons.
- The inhibition mechanism was found to be dependent on the Gαs pathway.
- MC4R agonist RO27-3225 increased c-Fos activity in several amygdala components in vivo.
Why It Matters
This research reveals a specific molecular mechanism for how Melanotan II and other melanocortins influence neuronal activity to control appetite. For peptide users, it suggests that the effects of compounds like Melanotan II on appetite suppression are partly mediated by a direct reduction in specific calcium channel activity in the amygdala. This understanding could eventually lead to more targeted therapies for eating disorders or obesity that modulate this specific MC4R to N-type channel pathway. The findings connect MC4R activation directly to presynaptic inhibition, providing a cellular explanation for its anorexigenic effects. However, this is preclinical work in cells and mice; translating this to human protocols requires significant further research into dosing, safety, and the complex interplay of brain circuits.
